Form 4: Edwards Lifesciences Executive Disposes of Shares for Tax Withholding
Insider Transaction Report
Annette Bruls, CVP, EMEACLA at Edwards Lifesciences Corp, disposed of 109 shares of common stock at $78.8 per share to satisfy tax withholding obligations.
Summary
- Annette Bruls, CVP, EMEACLA at Edwards Lifesciences Corp (EW), reported a transaction on July 11, 2025.
- The transaction involved the disposition of 109 shares of common stock.
- The shares were disposed of at a price of $78.8 per share.
- This disposition was coded as 'F', indicating it was made to satisfy tax withholding obligations.
- Following this transaction, Annette Bruls beneficially owns 14,171 shares of common stock directly.
Sentiment
Score: 5
Explanation: The transaction is a routine disposition of shares for tax withholding, which is a neutral event and does not indicate positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
No forward-looking statements or guidance are provided.
Industry Context
This Form 4 filing details a routine insider transaction for tax withholding purposes, which is common across all industries when equity awards vest. It does not provide specific insights into broader industry trends or competitive dynamics within the medical technology sector.
Related Party Transactions
- Annette Bruls, an officer of Edwards Lifesciences Corp, disposed of 109 shares of common stock to the issuer to satisfy tax withholding obligations related to equity awards. This is a direct transaction between an insider and the company.
Stakeholder Impact
- Shareholders: The transaction is a routine, small-scale disposition for tax purposes and is unlikely to have a material impact on the company's stock price or shareholder value.
- Employees: The transaction reflects a common practice for executives receiving equity compensation, indicating standard compensation practices are in place.
Key Dates
| Date | Description |
|---|---|
| 07/11/2025 | Date of transaction and filing of the Form 4. |
Keywords
Edwards Lifesciences, EW, Form 4, Insider Transaction, Share Disposition, Tax Withholding, Common Stock, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.